Moirai Biodesign is a company engaged in the engineering of RNA-based therapeutics and diagnostics for cancer. It develops a non-invasive test for in-situ diagnosis of diseases from patients' blood, in-vivo diagnosis systems for surgical assistance and patient monitoring, and disease-specific therapeutical drugs. The company builds a plug and play biodevice that is a structurally designed and synthetically engineered RNA molecule with a sensor, designed to target a specific disease biomarker, and a trigger, designed to encode a specific protein.